Radiotherapy represents a critical component in
cancer treatment. However,
premature ovarian failure (POF) is a major hurdle of deleterious off-target effects in young females, which, therefore, call for an effective
radioprotective agent. The present study aimed to explore the molecular mechanism underlying the protective effects of
N-acetyl-L-cysteine (NAC) against γ-radiation-provoked POF. Immature female Sprague-Dawley rats were orally-administered NAC (50 mg/kg) and were exposed to a single whole-body dose of 3.2 Gy ϒ-radiation. NAC administration remarkably reversed abnormal serum
estradiol and anti-Müllerian
hormone levels by 73% and 40%, respectively while ameliorating the histopathological and ultrastructural alterations-triggered by γ-radiation. Mechanistically, NAC alleviated radiation-induced oxidative damage through significantly increased
glutathione peroxidase activity by 102% alongside with decreasing
NADPH oxidase subunits (p22 and NOX4) gene expressions by 48% and 38%, respectively compared to the irradiated untreated group. Moreover, NAC administration achieved its
therapeutic effect by inhibiting ovarian apoptosis-induced by radiation through downregulating p53 and Bax levels by 33% and 16%, respectively while increasing the Bcl-2
mRNA expression by 135%. Hence, the Bax/Bcl2 ratio and
cytochrome c expression were subsequently reduced leading to decreased
caspase 3 activity by 43%. Importantly, the anti-apoptotic property of NAC could be attributed to inactivation of MAPK signaling molecules; p38 and JNK, and enhancement of the ovarian
vascular endothelial growth factor (
VEGF) expression. Taken together, our results suggest that NAC can inhibit
radiotherapy-induced POF while preserving ovarian function and structure through upregulating
VEGF expression and suppressing NOX4/MAPK/p53 apoptotic signaling.